Imunon, Inc. (IMNN)
1.56
-0.04
(-2.50%)
USD |
NASDAQ |
Sep 02, 16:00
1.58
+0.02
(+1.28%)
After-Hours: 20:00
Imunon Cash from Investing (Quarterly) : -0.0691M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0691M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.0036M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | -0.0173M |
| March 31, 2025 | -0.2597M |
| December 31, 2024 | -0.0149M |
| September 30, 2024 | -0.0029M |
| June 30, 2024 | 7.464M |
| March 31, 2024 | 2.382M |
| December 31, 2023 | -3.304M |
| September 30, 2023 | 10.67M |
| June 30, 2023 | 3.124M |
| March 31, 2023 | 0.5193M |
| December 31, 2022 | -10.83M |
| September 30, 2022 | 4.945M |
| June 30, 2022 | -2.549M |
| March 31, 2022 | 16.75M |
| December 31, 2021 | -0.9745M |
| September 30, 2021 | 3.006M |
| June 30, 2021 | -17.03M |
| March 31, 2021 | -15.12M |
| December 31, 2020 | -0.0052M |
| September 30, 2020 | 2.782M |
| June 30, 2020 | 7.096M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.949M |
| December 31, 2019 | 2.300M |
| September 30, 2019 | 5.278M |
| June 30, 2019 | 4.355M |
| March 31, 2019 | -5.997M |
| December 31, 2018 | 4.324M |
| September 30, 2018 | -5.116M |
| June 30, 2018 | 4.900M |
| March 31, 2018 | -5.74M |
| December 31, 2017 | -12.75M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.10M |
| March 31, 2017 | 1.659M |
| December 31, 2016 | 2.825M |
| September 30, 2016 | -2.361M |
| June 30, 2016 | -2.181M |
| March 31, 2016 | 10.78M |
| December 31, 2015 | 5.969M |
| September 30, 2015 | 1.956M |
| June 30, 2015 | 3.660M |
| March 31, 2015 | 1.742M |
| December 31, 2014 | 14.64M |
| September 30, 2014 | 0.7979M |
| June 30, 2014 | 4.190M |
| March 31, 2014 | -10.08M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 0.00 |
| Agenus, Inc. | 0.267M |
| Amgen, Inc. | -569.00M |
| Anika Therapeutics, Inc. | -1.28M |
| BioCryst Pharmaceuticals, Inc. | -110.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.026M |
| Cash from Financing (Quarterly) | 10.16M |
| Free Cash Flow | -15.18M |
| Free Cash Flow Per Share (Quarterly) | -0.5914 |
| Free Cash Flow to Equity (Quarterly) | -10.03M |
| Free Cash Flow to Firm (Quarterly) | -3.017M |
| Free Cash Flow Yield | -236.3% |